about
Redox mechanisms in hepatic chronic wound healing and fibrogenesisPromising Therapy Candidates for Liver FibrosisMesenchymal stem cell therapy for liver fibrosisRedox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequencesThe role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosisTGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunitiesModulation of glucose metabolism by the renin-angiotensin-aldosterone systemCellular and molecular mechanisms in the pathogenesis of liver fibrosis: An updateHepatitis C Virus (HCV) Proteins Induce NADPH Oxidase 4 Expression in a Transforming Growth Factor -Dependent Manner: a New Contributor to HCV-Induced Oxidative StressOxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticlesReactive oxygen species and fibrosis: further evidence of a significant liaisonPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesGATA binding protein 3 is correlated with leptin regulation of PPARγ1 in hepatic stellate cellsHepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverMechanisms of hepatic fibrogenesisCurrent status of novel antifibrotic therapies in patients with chronic liver diseaseRac1-mediated mitochondrial H2O2 generation regulates MMP-9 gene expression in macrophages via inhibition of SP-1 and AP-1Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.Animal models for the study of liver fibrosis: new insights from knockout mouse models.Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.Reactive oxygen species alter autocrine and paracrine signaling.A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defenceNox-2 is a modulator of fibrogenesis in kidney allograftsDietary Flavonoid Hyperoside Induces Apoptosis of Activated Human LX-2 Hepatic Stellate Cell by Suppressing Canonical NF-κB SignalingNADPH oxidase is implicated in the pathogenesis of oxidative phosphorylation dysfunction in mice fed a high-fat diet.Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex.Liver Injury and the Activation of the Hepatic Myofibroblasts.Deficiency of DJ-1 Ameliorates Liver Fibrosis through Inhibition of Hepatic ROS Production and InflammationEffects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis CModulation of reactive oxygen species by Rac1 or catalase prevents asbestos-induced pulmonary fibrosisRedox control of the cell cycle in health and disease.Thiol redox systems and protein kinases in hepatic stellate cell regulatory processes.Fibrogenesis in nonalcoholic steatohepatitis.Mechanisms of hepatic fibrogenesis.Anti-fibrogenic strategies and the regression of fibrosis.Inflammation and fibrogenesis in steatohepatitis.Curcumin and liver disease.
P2860
Q24656684-7E732BF2-D636-4CAB-BF08-33CAF0FBB947Q26766727-FFB466CE-FEC3-45D8-9E74-1BF4E22E3EDBQ26782128-5B12B667-B12D-4E90-9C33-F225F24BC31FQ26786129-4F2EA570-8374-4986-B02A-2F557EB32D11Q26797382-A29DAF63-21FF-46C2-AACA-5772CA5CDF91Q27022062-18B954AB-C945-425E-A421-0C1CD64C1F87Q27026157-8EA927B8-08B8-4EDB-955D-8BACFDDD4D0AQ27027703-CA05F9A6-824C-4146-8228-F01963C10670Q27490473-BDA67649-AF22-4367-8E4E-5273CA197BB1Q28075551-5B8ED80F-B649-431D-B86B-73990F293163Q28077930-5740BEBC-4ED3-4C8C-BF25-E20162C416F9Q28272678-D6BDA7B5-0370-4B74-A215-30DE9002B73AQ29048609-110543AB-3B5A-467F-B18C-DB0A5B239C52Q29616840-EA16F8FE-A8A1-4AAC-AA35-9B77B7D0A983Q29619336-CF13C0BB-78BE-4DBC-ADF3-DF6B14F56688Q30473375-4FFCCC7A-E28A-490E-AF2E-E8DFFF0BFC63Q34042822-06A9BBF3-F3C8-47F6-A99F-5AAB1827E13FQ34288768-589B15A8-765E-4191-BDD3-0528FF55948CQ34623238-3BE45712-F70C-4A7E-B47A-CEBF78803280Q34979933-BC9226E7-CD8D-4975-904B-C5DCAC9D92A1Q34992341-5AD4CA12-8762-4DA2-A4BD-039F69E551F7Q35559107-266C1B30-3C99-4FDC-B3E2-7ABCE5DCFD6BQ35928666-C397BC49-F254-47AA-A2A6-E9CBA97F9AE3Q35940373-DD3270E4-AF77-4D4E-89D5-F7117BAF56C6Q36611193-FF92024C-4375-4BA6-B7A8-1BA970B29937Q36783945-3A709957-8B21-4D5C-AB0B-3A2F90A56DDFQ36898694-32A34499-8678-48E0-B8FF-56F9D250A5CFQ37017917-01A2DB74-CA7F-4219-88D0-D3905294E107Q37108904-C98A4E44-F30B-411B-B9D6-7314F6B9C289Q37109402-678A2437-8CA7-4E90-A3B2-F969949AAF8AQ37348709-3FA43580-0ED1-42EA-B3A3-D9590B8873BFQ37391823-F98BDF48-4623-43CB-92FF-94A7D9BB2F9FQ37421274-73F3D348-40FE-42C6-B63C-D9505DC98D83Q37510851-909E6DC8-8E00-4334-90EF-0AB2A8694EF5Q37694585-13A81245-5957-4E4D-9930-F870BB609A92Q37863130-1DB4C20F-D574-4E45-8A91-F9B4C5385E56Q37865859-0FC86D7A-1920-4715-B6D9-C8BEA721A20AQ37865870-B2CA3BCF-F5A3-4E79-9D57-2BB65403F222Q37981867-D714A8A2-75DB-4BDD-81CA-145C027FBA7AQ38072883-9D60AF6E-EA59-4D84-8783-000F74F2806E
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
NOX in liver fibrosis
@en
type
label
NOX in liver fibrosis
@en
prefLabel
NOX in liver fibrosis
@en
P2860
P1476
NOX in liver fibrosis
@en
P2093
Samuele De Minicis
P2860
P304
P356
10.1016/J.ABB.2007.04.016
P407
P577
2007-05-02T00:00:00Z